BioLeonhardt LTP founded in 2013 is the flagship technology platform of Leonhardt Ventures and Leonhardt's Launchpads Utah, Inc. focused on heart regeneration. BioLeonhardt developed a combination three component system for heart regeneration comprised of (1) a bioelectric stimulator controlling release of regenerating promoting proteins including a stem cell homing factor, (2) an implantable, programmable and re-fillable micro infusion pump and (3) a fifteen component stem cell based heart regeneration composition.
| Website | http://www.bioleonhardt.com |
| Revenue | $5.9 million |
| Employees | View employees |
| Address | 12130 Millennium Dr, Los Angeles, California 90094, US |
| Phone | +1 310-310-2534 |
| Industry | Manufacturing General, Biotechnology, Monitoring Equipment, Manufacturing, Science and Engineering, Social/Platform Software, Electronics, Consumer Electronics, Hardware |
| Competitors | Thermo Fisher Scientific, Agilent Technologies, Merck Group, Bio-Rad Laboratories, Roche, Abbott, Illumina, QIAGEN, Molecular Devices, BD +40 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular BioLeonhardt employee's phone or email?
BioLeonhardt Questions
The BioLeonhardt annual revenue was $5.9 million in 2026.
BioLeonhardt is based in Los Angeles, California.
The NAICS codes for BioLeonhardt are [541, 54].
The SIC codes for BioLeonhardt are [873, 87].
